These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 28857608)

  • 1. Proteomic alterations of fibroblasts induced by ovarian cancer cells reveal potential cancer targets.
    Zhang XY; Hong SS; Zhang M; Cai QQ; Zhang MX; Xu CJ
    Neoplasma; 2018; 65(1):104-112. PubMed ID: 28857608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The chemokine growth-regulated oncogene 1 (Gro-1) links RAS signaling to the senescence of stromal fibroblasts and ovarian tumorigenesis.
    Yang G; Rosen DG; Zhang Z; Bast RC; Mills GB; Colacino JA; Mercado-Uribe I; Liu J
    Proc Natl Acad Sci U S A; 2006 Oct; 103(44):16472-7. PubMed ID: 17060621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomic analysis and identification of new biomarkers and therapeutic targets for invasive ovarian cancer.
    Jones MB; Krutzsch H; Shu H; Zhao Y; Liotta LA; Kohn EC; Petricoin EF
    Proteomics; 2002 Jan; 2(1):76-84. PubMed ID: 11788994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomic search for potential diagnostic markers and therapeutic targets for ovarian clear cell adenocarcinoma.
    Morita A; Miyagi E; Yasumitsu H; Kawasaki H; Hirano H; Hirahara F
    Proteomics; 2006 Nov; 6(21):5880-90. PubMed ID: 17022098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Orlistat, a novel potent antitumor agent for ovarian cancer: proteomic analysis of ovarian cancer cells treated with Orlistat.
    Huang HQ; Tang J; Zhou ST; Yi T; Peng HL; Shen GB; Xie N; Huang K; Yang T; Wu JH; Huang CH; Wei YQ; Zhao X
    Int J Oncol; 2012 Aug; 41(2):523-32. PubMed ID: 22581080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased WD-repeat containing protein 1 in interstitial fluid from ovarian carcinomas shown by comparative proteomic analysis of malignant and healthy gynecological tissue.
    Haslene-Hox H; Oveland E; Woie K; Salvesen HB; Wiig H; Tenstad O
    Biochim Biophys Acta; 2013 Nov; 1834(11):2347-59. PubMed ID: 23707566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer-associated fibroblasts secrete FGF-1 to promote ovarian proliferation, migration, and invasion through the activation of FGF-1/FGFR4 signaling.
    Sun Y; Fan X; Zhang Q; Shi X; Xu G; Zou C
    Tumour Biol; 2017 Jul; 39(7):1010428317712592. PubMed ID: 28718374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomic analysis of ovarian cancer cells during epithelial-mesenchymal transition (EMT) induced by epidermal growth factor (EGF) reveals mechanisms of cell cycle control.
    Grassi ML; Palma CS; Thomé CH; Lanfredi GP; Poersch A; Faça VM
    J Proteomics; 2017 Jan; 151():2-11. PubMed ID: 27394697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparative proteomics analysis of differentially expressed metastasis-associated proteins in human ovarian cancer cell lines].
    Su D; Xu SH; Gu LH
    Zhonghua Fu Chan Ke Za Zhi; 2005 Sep; 40(9):619-22. PubMed ID: 16202319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer-associated fibroblasts enhance the migration ability of ovarian cancer cells by increasing EZH2 expression.
    Xu L; Deng Q; Pan Y; Peng M; Wang X; Song L; Xiao M; Wang Z
    Int J Mol Med; 2014 Jan; 33(1):91-6. PubMed ID: 24212330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Identification of metastasis-associated proteins of ovarian cancer by proteomics].
    Zhou L; Yang XF; Wang Y; Zhang YT; Geng YP; Si LS; Wang YL
    Zhonghua Bing Li Xue Za Zhi; 2007 Dec; 36(12):814-8. PubMed ID: 18346353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibroblast activation protein regulates tumor-associated fibroblasts and epithelial ovarian cancer cells.
    Lai D; Ma L; Wang F
    Int J Oncol; 2012 Aug; 41(2):541-50. PubMed ID: 22614695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2D-DIGE analysis of ovarian cancer cell responses to cytotoxic gold compounds.
    Guidi F; Puglia M; Gabbiani C; Landini I; Gamberi T; Fregona D; Cinellu MA; Nobili S; Mini E; Bini L; Modesti PA; Modesti A; Messori L
    Mol Biosyst; 2012 Apr; 8(4):985-93. PubMed ID: 22134777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomic analysis of human epithelial ovarian cancer xenografts in immunodeficient mice exposed to chronic psychological stress.
    Gao J; Gao G; Zhang Y; Wang F
    Sci China Life Sci; 2011 Feb; 54(2):112-20. PubMed ID: 21318480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibroblast recruitment as a tool for ovarian cancer detection and targeted therapy.
    Oren R; Addadi Y; Narunsky Haziza L; Dafni H; Rotkopf R; Meir G; Fishman A; Neeman M
    Int J Cancer; 2016 Oct; 139(8):1788-98. PubMed ID: 27242346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transketolase is upregulated in metastatic peritoneal implants and promotes ovarian cancer cell proliferation.
    Ricciardelli C; Lokman NA; Cheruvu S; Tan IA; Ween MP; Pyragius CE; Ruszkiewicz A; Hoffmann P; Oehler MK
    Clin Exp Metastasis; 2015 Jun; 32(5):441-55. PubMed ID: 25895698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological responses to PDGF-AA versus PDGF-CC in renal fibroblasts.
    Seikrit C; Henkel C; van Roeyen CR; Bokemeyer D; Eitner F; Martin IV; Boor P; Knüchel R; Meyer HE; Müller-Newen G; Eriksson U; Floege J; Ostendorf T
    Nephrol Dial Transplant; 2013 Apr; 28(4):889-900. PubMed ID: 23229927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomic tracking of serum protein isoforms as screening biomarkers of ovarian cancer.
    Ahmed N; Oliva KT; Barker G; Hoffmann P; Reeve S; Smith IA; Quinn MA; Rice GE
    Proteomics; 2005 Nov; 5(17):4625-36. PubMed ID: 16220531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CLIC4 mediates TGF-beta1-induced fibroblast-to-myofibroblast transdifferentiation in ovarian cancer.
    Yao Q; Qu X; Yang Q; Wei M; Kong B
    Oncol Rep; 2009 Sep; 22(3):541-8. PubMed ID: 19639201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Profiling signatures of ovarian cancer tumour suppression using 2D-DIGE and 2D-LC-MS/MS with tandem mass tagging.
    Sinclair J; Metodieva G; Dafou D; Gayther SA; Timms JF
    J Proteomics; 2011 Apr; 74(4):451-65. PubMed ID: 21237297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.